{
 "id": "heart-failure",
 "name": "Heart failure",
 "aliases": [
  "Heart Failure",
  "Heart failure (HF)"
 ],
 "acronyms": [
  "HF"
 ],
 "bodySystem": "cardiovascular",
 "parent": null,
 "children": [
  "chronic-heart-failure"
 ],
 "edition": "2026-11",
 "merkleRoot": "006ab9a329709cbe7f56a0e1a7c4a02f897655cdfecf9ca34d199690095adcb6",
 "builtFrom": "program.status and program.eligibility facts, grouped by the condition registry",
 "counts": {
  "open": 1,
  "limited": 0,
  "waitlist": 1,
  "closed": 1
 },
 "funds": [
  {
   "fund": "Heart failure (HF) health equity",
   "organization": "TotalAssist (Patient Advocate Foundation copay funds)",
   "status": "open",
   "dateOnPage": null,
   "awardLevelUsd": 2500,
   "insuranceTypes": [
    "Medicaid",
    "Medicare",
    "TRICARE"
   ],
   "pageSays": "The page lists the fund as Open.",
   "readOn": "2026-11-08",
   "source": "https://totalassist.org/funds/"
  },
  {
   "fund": "Heart Failure",
   "organization": "Accessia Health",
   "status": "waitlist",
   "dateOnPage": null,
   "awardLevelUsd": null,
   "insuranceTypes": null,
   "pageSays": "The program page lists the program as At Capacity, Waitlist Open. Its tracks: privately insured track waitlist open (at capacity); publicly insured track waitlist open (at capacity). It shows no date.",
   "readOn": "2026-11-10",
   "source": "https://accessiahealth.org/program/heart-failure/"
  },
  {
   "fund": "Heart failure (HF)",
   "organization": "TotalAssist (Patient Advocate Foundation copay funds)",
   "status": "closed",
   "dateOnPage": null,
   "awardLevelUsd": 2500,
   "insuranceTypes": [
    "Medicaid",
    "Medicare",
    "TRICARE"
   ],
   "pageSays": "The page lists the fund as Closed.",
   "readOn": "2026-11-08",
   "source": "https://totalassist.org/funds/"
  }
 ],
 "drugsWhoseLabelNamesThisCondition": [
  {
   "ingredient": "DAPAGLIFLOZIN",
   "pages": [
    {
     "brand": "Farxiga",
     "url": "https://omnirx.org/negotiated-drugs/farxiga"
    }
   ],
   "labelSentence": "To reduce the risk of CV death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure.",
   "labelContext": "risk-reduction",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%2201f90c94-71cb-4a1f-81ff-8004b850529b%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [
    {
     "name": "Farxiga Savings (via AstraZeneca)",
     "url": "https://omnirx.org/assistance/farxiga-patient-assistance",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": null,
     "status": null,
     "statusRead": null
    },
    {
     "name": "Heart Medication Assistance (Multiple Programs)",
     "url": "https://omnirx.org/assistance/heart-medication-assistance",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": null,
     "status": null,
     "statusRead": null
    },
    {
     "name": "Diabetes Medication Assistance (Multiple Programs)",
     "url": "https://omnirx.org/assistance/diabetes-medication-assistance",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": null,
     "status": null,
     "statusRead": null
    },
    {
     "name": "AZ&Me Prescription Savings Program",
     "url": "https://omnirx.org/assistance/astrazeneca-azandme",
     "programPageIsExternal": false,
     "inCurrentList": false,
     "note": null,
     "listKind": "Important Program Updates page: product additions and removals only (not the full list)",
     "status": null,
     "statusRead": null
    }
   ],
   "medicareNegotiatedPrice": {
    "usd30DaySupply": 183.33,
    "effective": "2027-01-01",
    "source": "https://www.cms.gov/initiatives/medicare-prescription-drug-affordability/overview/medicare-drug-price-negotiation-program/selected-drugs-negotiated-prices"
   }
  },
  {
   "ingredient": "EMPAGLIFLOZIN",
   "pages": [
    {
     "brand": "Jardiance",
     "url": "https://omnirx.org/negotiated-drugs/jardiance"
    }
   ],
   "labelSentence": "... to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure.",
   "labelContext": "risk-reduction",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%221782b947-4a72-4feb-a488-1469d9af82bd%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [
    {
     "name": "Jardiance Savings (via Boehringer Ingelheim/Lilly)",
     "url": "https://omnirx.org/assistance/jardiance-patient-assistance",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": null,
     "status": null,
     "statusRead": null
    },
    {
     "name": "Heart Medication Assistance (Multiple Programs)",
     "url": "https://omnirx.org/assistance/heart-medication-assistance",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": null,
     "status": null,
     "statusRead": null
    },
    {
     "name": "Diabetes Medication Assistance (Multiple Programs)",
     "url": "https://omnirx.org/assistance/diabetes-medication-assistance",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": null,
     "status": null,
     "statusRead": null
    },
    {
     "name": "Boehringer Ingelheim Cares Foundation",
     "url": "https://omnirx.org/assistance/boehringer-ingelheim-cares",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": null,
     "status": "limited",
     "statusRead": "2026-11-06"
    }
   ],
   "medicareNegotiatedPrice": {
    "usd30DaySupply": 202.33,
    "effective": "2027-01-01",
    "source": "https://www.cms.gov/initiatives/medicare-prescription-drug-affordability/overview/medicare-drug-price-negotiation-program/selected-drugs-negotiated-prices"
   }
  },
  {
   "ingredient": "Empagliflozin/Metformin HCl",
   "pages": [
    {
     "brand": "Synjardy XR",
     "url": "https://omnirx.org/medicines/synjardy-xr"
    },
    {
     "brand": "Synjardy",
     "url": "https://omnirx.org/medicines/synjardy"
    }
   ],
   "labelSentence": "CV death and hospitalization for heart failure in adults with heart failure.",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%220fdd0255-0055-65f3-b2c0-db8fbb87beae%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [
    {
     "name": "Boehringer Ingelheim Cares Foundation",
     "url": "https://omnirx.org/assistance/boehringer-ingelheim-cares",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": null,
     "status": "limited",
     "statusRead": "2026-11-06"
    }
   ],
   "medicareNegotiatedPrice": null
  },
  {
   "ingredient": "Finerenone",
   "pages": [
    {
     "brand": "Kerendia",
     "url": "https://omnirx.org/medicines/kerendia"
    }
   ],
   "labelSentence": "... cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adult patients with heart failure with left ventricular ejection fraction (LVEF) ≥ 40%.",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%22fc726765-5d5a-4d6e-b037-b847bda9fb7c%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [
    {
     "name": "Bayer US Patient Assistance Foundation",
     "url": "https://www.patientassistance.bayer.us/en/about/bayer-products",
     "programPageIsExternal": true,
     "inCurrentList": true,
     "note": null,
     "listKind": "Bayer prescription medicines included in the program",
     "status": null,
     "statusRead": null
    }
   ],
   "medicareNegotiatedPrice": null
  },
  {
   "ingredient": "Vutrisiran Sodium",
   "pages": [
    {
     "brand": "Amvuttra",
     "url": "https://omnirx.org/medicines/amvuttra"
    }
   ],
   "labelSentence": "... the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis in adults to reduce cardiovascular mortality, cardiovascular hospitalizations and urgent heart failure visits ( 1.",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%228db0facb-81b6-4006-9239-27dc6409c5d3%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [],
   "medicareNegotiatedPrice": null
  }
 ],
 "fundsForRelatedCosts": [],
 "note": "Each status is what the fund page said on readOn. It is not an eligibility determination. We hold only the organizations we read; no fund here does not mean no fund exists.",
 "licence": "CC BY 4.0 for the OmniRx compilation"
}